Abstract
The pathogenesis of Sydenham's (rheumatic) chorea is not well understood. Laboratory tests are not helpful in establishing the diagnosis. The chorea can be successfully treated with haloperidol, an agent known to interfere with the binding of dopamine to its receptors. This suggests that dopamine, and its urine catabolite homovanylic acid (HVA), might be increased in Sydenham's chorea. To test this hypothesis the urines of three patients with the clinical diagnosis of Sydenham's chorea were analyzed for HVA and Vanyllylmandel acid (VMA) during the acute phase of the disease. Urine HVA was 28.07 ± 6.1 mcg per mg. creatinine (m ± SEM). Seven age matched control children had urine HVA levels of 8.8 ± 0.7 mcg per mg creatinine (m ± SEM) (p< 0.01). Urinary VMA was 8.7 ± 3.2 mcg per mg creatinine in the patients with chorea, and 6.4 ± 0.6 in the control group (p> 0.1). The ratio HVA:VMA was 3.7 ± 0.7 (m ± SEM) in the 3 patients, with chorea and 1.4 ± 0.2 in the control group (p< 0.005). In conclusion, urine HVA is increased in patients with Sydenham's chorea, suggesting increased dopamine, the metabolic precursor of HVA, in the disease. The determination of HVA and HVA:VMA ratio may be helpful in establishing this diagnosis.
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hochberg, Z., Winter, S. 1131 ABNORMAL CATECHOLAMINE EXCRETION IN PATIENTS WITH SYDENHAM'S CHOREA. Pediatr Res 12 (Suppl 4), 552 (1978). https://doi.org/10.1203/00006450-197804001-01137
Issue date:
DOI: https://doi.org/10.1203/00006450-197804001-01137
